- Home
- IOVA vs NSSC Comparison
IOVA vs NSSC Comparison
Compare IOVA & NSSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IOVA
- NSSC
- Stock Information
- Founded
- IOVA 2007
- NSSC 1969
- Country
- IOVA United States
- NSSC United States
- Employees
- IOVA N/A
- NSSC N/A
- Industry
- IOVA Biotechnology: Biological Products (No Diagnostic Substances)
- NSSC Telecommunications Equipment
- Sector
- IOVA Health Care
- NSSC Telecommunications
- Exchange
- IOVA Nasdaq
- NSSC Nasdaq
- Market Cap
- IOVA 3.6B
- NSSC 2.1B
- IPO Year
- IOVA N/A
- NSSC N/A
- Fundamental
- Price
- IOVA $10.01
- NSSC $34.37
- Analyst Decision
- IOVA Strong Buy
- NSSC Strong Buy
- Analyst Count
- IOVA 10
- NSSC 7
- Target Price
- IOVA $24.80
- NSSC $51.71
- AVG Volume (30 Days)
- IOVA 7.0M
- NSSC 982.3K
- Earning Date
- IOVA 11-05-2024
- NSSC 11-04-2024
- Dividend Yield
- IOVA N/A
- NSSC 1.46%
- EPS Growth
- IOVA N/A
- NSSC 83.56
- EPS
- IOVA N/A
- NSSC 1.34
- Revenue
- IOVA $32,772,000.00
- NSSC $188,820,000.00
- Revenue This Year
- IOVA $13,836.92
- NSSC $15.06
- Revenue Next Year
- IOVA $183.20
- NSSC $16.11
- P/E Ratio
- IOVA N/A
- NSSC $25.54
- Revenue Growth
- IOVA 13669.75
- NSSC 11.07
- 52 Week Low
- IOVA $3.21
- NSSC $17.76
- 52 Week High
- IOVA $18.33
- NSSC $58.09
- Technical
- Relative Strength Index (RSI)
- IOVA 46.05
- NSSC 24.80
- Support Level
- IOVA $10.32
- NSSC $31.79
- Resistance Level
- IOVA $11.80
- NSSC $48.75
- Average True Range (ATR)
- IOVA 0.60
- NSSC 2.83
- MACD
- IOVA -0.22
- NSSC -1.87
- Stochastic Oscillator
- IOVA 11.86
- NSSC 12.07
About IOVA Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.
About NSSC NAPCO Security Technologies Inc.
NAPCO Security Technologies Inc manufactures security products, encompassing access control systems, door-locking products, intrusion and fire alarm systems and video surveillance products. Its products are used for various applications which includes alarm systems like automatic communicators, combination control panels/digital communicators and digital keypad systems, fire alarm control panel and area detectors mainly used for commercial, residential, institutional, industrial and governmental uses.